Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Roivant Sciences (ROIV) Non Operating Investment Income: 2020-2025

Historic Non Operating Investment Income for Roivant Sciences (ROIV) over the last 5 years, with Sep 2025 value amounting to $128.5 million.

  • Roivant Sciences' Non Operating Investment Income rose 165.64% to $128.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $136.4 million, marking a year-over-year increase of 1772.85%. This contributed to the annual value of $55.2 million for FY2025, which is 215.04% up from last year.
  • As of Q3 2025, Roivant Sciences' Non Operating Investment Income stood at $128.5 million, which was up 771.90% from -$19.1 million recorded in Q2 2025.
  • Over the past 5 years, Roivant Sciences' Non Operating Investment Income peaked at $443.8 million during Q3 2021, and registered a low of -$54.7 million during Q3 2022.
  • For the 3-year period, Roivant Sciences' Non Operating Investment Income averaged around $11.0 million, with its median value being -$9.0 million (2023).
  • In the last 5 years, Roivant Sciences' Non Operating Investment Income surged by 426.42% in 2021 and then crashed by 225.61% in 2025.
  • Over the past 5 years, Roivant Sciences' Non Operating Investment Income (Quarterly) stood at -$38.0 million in 2021, then skyrocketed by 168.22% to $25.9 million in 2022, then tumbled by 140.34% to -$10.5 million in 2023, then slumped by 103.63% to -$21.3 million in 2024, then soared by 165.64% to $128.5 million in 2025.
  • Its last three reported values are $128.5 million in Q3 2025, -$19.1 million for Q2 2025, and -$21.3 million during Q4 2024.